Until I was diagnosed with stage I triple-negative breast cancer in December 2016, I didn’t know much about immunotherapy. But as an executive assistant in MD Anderson’s Radiation Oncology department for more than 25 years, I’d heard the term used before by our doctors. I never thought that one day it would save my own life.

When I started my treatment, I joined a clinical trial being conducted by MD Anderson’s Breast Cancer Moon...